Contrastive Learning for Predicting Cancer Prognosis Using Gene Expression Values

Overview

• This paper explores how contrastive learning (CL) can be used to learn good feature representations from limited data, and then apply those learned features to classify tumors and predict cancer prognosis.
• The researchers demonstrated that CL-based classifiers and Cox models can outperform existing methods for 19 types of cancer, using data from The Cancer Genome Atlas (TCGA) and two independent validation cohorts.
• CL-based tools for cancer prognosis prediction are made publicly available for use with RNA-seq data.

Plain English Explanation

Contrastive learning is a technique that can learn useful features from a small amount of data by comparing and contrasting different examples. In this paper, the researchers applied contrastive learning to learn features from tumor gene expression data and clinical information.

They then used these learned features to train classifiers that can categorize tumors as high-risk or low-risk for recurrence. The researchers found that their contrastive learning-based classifiers achieved very good performance, with an area under the curve (AUC) greater than 0.8 for 14 cancer types, and greater than 0.9 for 2 cancer types.

The researchers also developed contrastive learning-based Cox models, which are a type of statistical model used to predict a patient's prognosis or survival time. These contrastive learning-based Cox models outperformed existing methods for predicting prognosis in 19 different cancer types.

The performance of these contrastive learning-based tools was validated using independent cancer patient datasets, showing their potential for real-world application. The researchers have also made these tools publicly available, so that they can be used to predict cancer prognosis from RNA sequencing data.

Technical Explanation

The researchers applied contrastive learning to tumor transcriptome and clinical data to learn feature representations in a low-dimensional space. They then used these learned features to train classifiers to categorize tumors into high- or low-risk groups for recurrence.

Using data from The Cancer Genome Atlas (TCGA), the researchers demonstrated that their contrastive learning-based classifiers achieved an AUC greater than 0.8 for 14 types of cancer, and an AUC greater than 0.9 for 2 types of cancer. They also developed contrastive learning-based Cox models for predicting cancer prognosis, which outperformed existing methods significantly for 19 types of cancer.

The performance of the contrastive learning-based classifiers and Cox models was validated using data from two independent cohorts for lung and prostate cancer. The researchers also showed that their contrastive learning-based Cox model for breast cancer outperformed the Cox model trained on the 21 genes used in the clinically-used Oncotype DX test.

Critical Analysis

The researchers have demonstrated the potential of contrastive learning for improving cancer prognosis prediction, but there are some limitations to consider:

• The study was limited to 19 cancer types, and the performance of the contrastive learning-based tools may vary for other cancer types.
• The researchers used data from TCGA, which may not be representative of all cancer patient populations. Additional validation using more diverse datasets would be valuable.
• The interpretability of the contrastive learning-based models is not discussed, which could be an important consideration for clinical applications.
• The researchers did not explore the use of contrastive learning for social media text or long-tailed multi-label classification, which could be relevant for other cancer-related applications.

Conclusion

This paper demonstrates the potential of contrastive learning to improve cancer prognosis prediction by learning useful features from limited data. The publicly available contrastive learning-based tools for cancer prognosis prediction could be valuable for clinicians and researchers, but further validation and exploration of model interpretability would be important next steps. Overall, this research highlights the promise of contrastive learning for improving disease detection and prediction from complex biomedical data.